-
1دورية أكاديمية
المؤلفون: Mateos, María-Victoria1 mvmateos@usal.es, Hernández, Miguel-Teodoro2, Giraldo, Pilar3, de la Rubia, Javier4, de Arriba, Felipe5, Corral, Lucía López1, Rosiñol, Laura6, Paiva, Bruno7, Palomera, Luis8, Bargay, Joan9, Oriol, Albert10, Prosper, Felipe7, López, Javier11, Arguiñano, José-María12, Quintana, Nuria13, García, José-Luis13, Bladé, Joan6, Lahuerta, Juan-José14, Miguel, Jesús-F San7
المصدر: Lancet Oncology. Aug2016, Vol. 17 Issue 8, p1127-1136. 10p.
مصطلحات موضوعية: *MULTIPLE myeloma treatment, *DEXAMETHASONE, *MULTIPLE myeloma, *MEDICAL protocols, *CLINICAL trials, *DISEASE risk factors, *ANTINEOPLASTIC agents, *COMPARATIVE studies, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *PROGNOSIS, *RESEARCH, *SURVIVAL, *THALIDOMIDE, *TUMOR classification, *EVALUATION research, *RANDOMIZED controlled trials, *CASE-control method
-
2دورية أكاديمية
المؤلفون: Jakubowiak, Andrzej1 ajakubowiak@medicine.bsd.uchicago.edu, Offidani, Massimo2, Pégourie, Brigitte3, De La Rubia, Javier4, Garderet, Laurent5, Laribi, Kamel6, Bosi, Alberto7, Marasca, Roberto8, Laubach, Jacob9, Mohrbacher, Ann10, Carella, Angelo Michele11, Singhal, Anil K.12, Tsao, L. Claire12, Lynch, Mark13, Bleickardt, Eric13, Ying-Ming Jou14, Robbins, Michael15, Palumbo, Antonio16
المصدر: Blood. 6/9/2016, Vol. 127 Issue 23, p2833-2840. 8p.
مصطلحات موضوعية: *RANDOMIZED controlled trials, *MULTIPLE myeloma, *DISEASE progression, *ALLELES, *IMMUNOLOGICAL adjuvants, *PATIENTS
-
3دورية أكاديمية
المؤلفون: Rosiñol, Laura1, Oriol, Albert2, Teruel, Ana Isabel3, Hernández, Dolores4, López-Jiménez, Javier5, de la Rubia, Javier6, Granell, Miquel7, Besalduch, Joan8, Palomera, Luis9, González, Yolanda10, Etxebeste, Ma Asunción11, Díaz-Mediavilla, Joaquín12, Hernández, Miguel T.13, de Arriba, Felipe14, Gutiérrez, Norma C.15, Martín-Ramos, Ma Luisa16, Cibeira, Ma Teresa1, Mateos, Ma Victoria15, Martínez, Joaquín16, Alegre, Adrián17
المصدر: Blood. 8/23/2012, Vol. 120 Issue 8, p1589-1596. 8p.
مصطلحات موضوعية: *THALIDOMIDE, *DEXAMETHASONE, *MULTIPLE myeloma treatment, *PROTEASOME inhibitors, *STEM cell transplantation, *RANDOMIZED controlled trials, *MEDICAL statistics